Trumponomics (Part 4): Deregulation
President Trump believes that deregulation, lower taxes, and infrastructure spending will help the economy grow faster, and his economic agenda could help create millions of high paying jobs for his supporters. But really how much does deregulation really play in the economic growth?
Trumponomics (Part 3): Infrastructure
Infrastructure spending could be the most important economic effort the Trump administration pursues. The benefits include ... U.S. infrastructure repair and maintenance is sorely needed. Infrastructure spending does have a positive multiplier effect...Infrastructure projects could put people to work across the country...Infrastructure investments could increase the productivity of America.
Trumponomics (Part 2): Tax Reform
In this month's issue we analyze President Trump’s tax proposals. His effort to push through a 15% Corporate Tax Rate, end the Estate Tax, and reduce the Personal Income Tax to Three Brackets 10%, 25% and 35% while eliminating the Mortgage Interest and State Tax Deductions. Is this a ticket to a $30 Trillion Dollar Debt or a way to push economic growth to 4%, 5% or 6% as he promised when he was running for office?
Trumponomics (Part 1): Overview
It's time to take the rose colored glasses off and be realistic about what the Trump Administration is going to mean for both the U.S. Economy and World's Financial Markets.
Sell Call Options Against Your Shares of BlueBird Bio
Lower your cost basis 28%. We did this before and racked up a 32% profit. Let's do it again.
New Buy Recommendation: Grab Your Shares On Monday!
BUY 300 Shares BioTech for $42 or less a share... 12-18 month price target $70 a share which gives you upside as much 65% to 75% in the next 12-18 months. The firm is a solid Buyout Candidate after FDA approval of its first drug!
We were stopped out of both our PNAT and NAK positions thanks to our strict 20% stop loss rule.
We also took a 32.78% on BLUE via our covered call options recommendation. Here's what I recommend to do now.
Radius Health (RDUS) is starting what appears to make a big move!
Keep an eye on your 300 shares of RDUS. I may be recommending to take profits or more likley to sell some covered call options against your shares... in a matter of weeks or even days.
Pure Naturals Surges (PNAT) After Dipping Below Recommended Re-entry Price.
Here's what I want recommend next.
Pure Nationals (PNAT-OTC) Back in this company's shares
I believe PNAT could rocket back to $3+ a share and eventually to over $12. Keep in mind this is a flyer stock that is higher risk than many other stocks I have and will recommend in World Opportunity Trader. Read my disclosure regarding PNAT in my welcome letter.
Tom McClellan warns: "Treasury-Bund Spread Gives Early Warning of the End" of Bull Market on Wall Street
Tom McClellan in my opinion is one of the best market timers in the world for stocks, commodities and currencies. This week he issued this special update regarding the current bull market on Wall Street. It's going to end. Not now but soon.
Science Fiction Discoveries That Could Make You Rich
Five companies with disruptive technologies that sound like they’re right out of the pages of a science fiction novel ... but are actually much closer to reality than most investors realize.
Cleaning Up with Pura Naturals Revolutionary Sponges!
Why I believe Pura Naturals’shares have the potential to hand shareholders
up to a 686% gain over the next 4 years.*
Serial Killer - 3 Companies on the Verge of Curing Cancer That Could Be Commercialized in the Next 48 Months
Get ready for some incredible breakthroughs in medicine and science that will change the world we live in for the better.
7 Secrets for Finding Stocks That Soar
They can also be used to find stocks that are going to Plummet!